Hydreight Technologies Inc NURS

Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a healthcare technology company operating a nationwide physician-supervised healthcare platform with a network of more than 300 licensed physicians, more than 3,000 licensed nurses, and pharmacy partners serving all 50 U.S. states, is pleased to announce that it has been invited to participate in Canaccord Genuity's 46th Annual Growth Conference, taking place August 11–13, 2026, at the InterContine

Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) is providing shareholders with an update following today's news release issued by Hydreight Technologies Inc. ("Hydreight") regarding the recommendations of the U.S. Food and Drug Administration ("FDA") Pharmacy Compounding Advisory Committee ("PCAC") relating to certain peptide-related bulk drug substances.

Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (FSE: SO6) (OTCQB: HYDTF), a digital health platform connecting healthcare providers, pharmacies and patients across the United States, today provided an update on its peptide healthcare platform following the recent recommendations of the U.S. Food and Drug Administration's ("FDA") Pharmacy Compounding Advisory Committee ("PCAC").

Hydreight Technologies Inc (HYDTF) reports a record $25 million in revenue, achieving profitability and reaffirming strong growth guidance despite challenges in the regulatory landscape.

As Canadian markets face challenges with a technical recession and persistent inflation pressures, investors are keenly assessing the landscape for opportunities. In such an environment, identifying stocks that may be priced below their estimated value becomes crucial, as these could offer potential upside when market conditions stabilize.

Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, announces that it has refiled its condensed interim consolidated financial statements for the three months ended March 31, 2026 and 2025 on SEDAR+ to correct classification errors contained within the segment financial information and disaggregation of revenue disclosures included in Note 16 – Operating Segments, relating to pharmacy sales with

Victory Square Technologies Inc. (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) ("Victory Square", "VST", or the "Company"), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence, and emerging technology platforms, today announced its financial results for the three months ended March 31, 2026.

Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, is pleased to report its financial results for the three months ended March 31, 2026. All figures are in Canadian dollars unless otherwise stated. All references to Non-GAAP Financial Measures are as reported in the Company's Management Discussion and Analysis ("MD&A").

Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing digital health platform and provider of compliant healthcare infrastructure across the United States, today announced that the Company will release its first quarter 2026 financial results after market close on Monday, June 1, 2026.

Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) ("Victory Square" or the "Company"), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence, and emerging technology platforms, today reported its audited financial results for the year ended December 31, 2025 and provided a corporate update across its portfolio.